Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Chin J Integr Med. 2011 Nov;17(11):873-80. doi: 10.1007/s11655-011-0796-x. Epub 2011 Aug 1.
Heart failure (HF) is a severe heart disease. The use of autologous bone marrow stem cells (BMCs) mobilization in the treatment of HF has been a hot topic to research both in Western medicine and Chinese medicine (CM). There are many clinical trials and experiments on study of BMCs mobilization for HF therapy, including integrative medicine. The effect of BMCs mobilization is favorable for cardiac repair, while some advantages of CM support the advanced study of its application in BMCs mobilization to treat HF. In addition, with mechanisms of autologous BMCs mobilization for the treatment of HF that will be revealed in the future, especially stem cells niches, integrative medicine would play an important role in this clinical thought of therapy model gradually. Simultaneously, CM should adapt the new approaches of stem cells progresses on HF treatment as holding characteristics of itself.
心力衰竭(HF)是一种严重的心脏病。自体骨髓干细胞(BMCs)动员在 HF 治疗中的应用一直是西医和中医(CM)研究的热点。有许多关于 BMCs 动员治疗 HF 的临床试验和实验,包括整合医学。BMCs 动员的效果有利于心脏修复,而 CM 的一些优势支持其在 BMCs 动员治疗 HF 中的应用的深入研究。此外,随着未来自体 BMCs 动员治疗 HF 的机制被揭示,特别是干细胞龛,整合医学将在这种治疗模式的临床思维中发挥重要作用。同时,CM 应该适应 HF 治疗中干细胞进展的新方法,保持自身的特点。